FDA approves PrEP drug. Lenacapavir is a twice-yearly HIV prevention shot more effective than daily pills.
The Biden administration is releasing an additional 1.8 million doses of the monkeypox vaccine to various localities.
Merck said results of a study into islatravir suggested it could be used to prevent and treat HIV